Behavioral Problems in Dementia: A Factor Analysis of the Neuropsychiatric Inventory (original) (raw)

Skip Nav Destination

Article navigation

Issue Cover

Research Articles| January 20 2003

Pauline Aalten;

aBrain and Behavior Institute, University of Maastricht, and

Search for other works by this author on:

Marjolein E. de Vugt;

aBrain and Behavior Institute, University of Maastricht, and

Search for other works by this author on:

Richel Lousberg;

aBrain and Behavior Institute, University of Maastricht, and

Search for other works by this author on:

Edith Korten;

aBrain and Behavior Institute, University of Maastricht, and

Search for other works by this author on:

Niek Jaspers;

bDepartment of Mental Health of the Elderly, RIAGG Maastricht, The Netherlands

Search for other works by this author on:

Birgit Senden;

aBrain and Behavior Institute, University of Maastricht, and

Search for other works by this author on:

Jelle Jolles;

aBrain and Behavior Institute, University of Maastricht, and

Search for other works by this author on:

Frans R.J. Verhey

aBrain and Behavior Institute, University of Maastricht, and

Search for other works by this author on:

Dement Geriatr Cogn Disord (2003) 15 (2): 99–105.

Content Tools

Abstract

The aim of this study was to detect behavioral subsyndromes of the 12-item Neuropsychiatric Inventory (NPI). Cross-sectional data of 199 patients with dementia living in the community were collected. Principal component analysis (with Varimax rotation) was used for factor analysis. Results showed the presence of three behavioral subsyndromes: mood/apathy, psychosis, and hyperactivity. Anxiety was regarded as a separate symptom. The subsyndrome mood/apathy was the most common, occurring in almost 80% of the patients, versus psychosis and hyperactivity, which occurred in 37 and 60% of the patients, respectively.

This content is only available via PDF.

© 2003 S. Karger AG, Basel

2003

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.

Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

You do not currently have access to this content.

Sign in

Digital Version

Pay-Per-View Access

$39.00

1 Karger Article Bundle Token

$150

Rental

This article is also available for rental through DeepDyve.